GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioCardia Inc (NAS:BCDA) » Definitions » Cyclically Adjusted PB Ratio

BioCardia (BioCardia) Cyclically Adjusted PB Ratio : 0.11 (As of Apr. 30, 2024)


View and export this data going back to 1996. Start your Free Trial

What is BioCardia Cyclically Adjusted PB Ratio?

As of today (2024-04-30), BioCardia's current share price is $0.3772. BioCardia's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $3.30. BioCardia's Cyclically Adjusted PB Ratio for today is 0.11.

The historical rank and industry rank for BioCardia's Cyclically Adjusted PB Ratio or its related term are showing as below:

BCDA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.84   Max: 14.19
Current: 0.11

During the past years, BioCardia's highest Cyclically Adjusted PB Ratio was 14.19. The lowest was 0.11. And the median was 0.84.

BCDA's Cyclically Adjusted PB Ratio is ranked better than
88.3% of 641 companies
in the Biotechnology industry
Industry Median: 1.74 vs BCDA: 0.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioCardia's adjusted book value per share data for the three months ended in Dec. 2023 was $-0.068. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.30 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


BioCardia Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioCardia's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCardia Cyclically Adjusted PB Ratio Chart

BioCardia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.74 0.44 0.52 0.20

BioCardia Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.51 0.72 0.12 0.20

Competitive Comparison of BioCardia's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, BioCardia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCardia's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioCardia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioCardia's Cyclically Adjusted PB Ratio falls into.



BioCardia Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioCardia's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.3772/3.3
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCardia's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, BioCardia's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.068/129.4194*129.4194
=-0.068

Current CPI (Dec. 2023) = 129.4194.

BioCardia Quarterly Data

Book Value per Share CPI Adj_Book
201403 6.272 99.695 8.142
201406 6.303 100.560 8.112
201409 6.323 100.428 8.148
201412 6.352 99.070 8.298
201503 6.387 99.621 8.297
201506 6.422 100.684 8.255
201509 6.422 100.392 8.279
201512 6.503 99.792 8.434
201603 6.541 100.470 8.426
201606 6.576 101.688 8.369
201609 8.965 101.861 11.390
201612 4.858 101.863 6.172
201703 4.330 102.862 5.448
201706 3.795 103.349 4.752
201709 3.252 104.136 4.042
201712 2.620 104.011 3.260
201803 1.932 105.290 2.375
201806 1.354 106.317 1.648
201809 0.692 106.507 0.841
201812 0.783 105.998 0.956
201903 0.169 107.251 0.204
201906 -0.461 108.070 -0.552
201909 0.761 108.329 0.909
201912 0.347 108.420 0.414
202003 -0.187 108.902 -0.222
202006 0.587 108.767 0.698
202009 0.331 109.815 0.390
202012 1.177 109.897 1.386
202103 1.105 111.754 1.280
202106 0.929 114.631 1.049
202109 0.795 115.734 0.889
202112 0.615 117.630 0.677
202203 0.437 121.301 0.466
202206 0.379 125.017 0.392
202209 0.230 125.227 0.238
202212 0.244 125.222 0.252
202303 0.094 127.348 0.096
202306 0.076 128.729 0.076
202309 -0.031 129.860 -0.031
202312 -0.068 129.419 -0.068

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioCardia  (NAS:BCDA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioCardia Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioCardia's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioCardia (BioCardia) Business Description

Industry
Traded in Other Exchanges
Address
320 Soquel Way, Sunnyvale, CA, USA, 94085
BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular and pulmonary diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Bill Facteau director C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE CA 94085
Frost Gamma Investments Trust 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137
Krisztina M Zsebo director C/O CELLADON CORPORATION, 12760 HIGH BLUFF DRIVE, SUITE 240, SAN DIEGO CA 92130
Edward M Gillis officer: Senior Vice President, Devices C/O BIOCARDIA, INC., 125 SHOREWAY ROAD, SUITE B, SAN CARLOS CA 94070
Andrew Scott Blank director C/O BIOCARDIA, INC., 125 SHOREWAY ROAD, SUITE B, SAN CARLOS CA 94070
Jim L. Allen director C/O BIOCARDIA, INC., 125 SHOREWAY ROAD, SUITE B, SAN CARLOS CA 94070
Simon H Stertzer director C/O BIOCARDIA, INC., 125 SHOREWAY DRIVE, SUITE B, SAN CARLOS CA 94070
Peter Altman director, officer: President and CEO C/O BIOCARDIA INC, 125 SHOREWAY ROAD SUITE B, SAN CARLOS CA 94070
Stertzer Family Trust 10 percent owner C/O BIOCARDIA INC, 125 SHOREWAY ROAD SUITE B, SAN CARLOS CA 94070
Kimberly Stertzer 10 percent owner C/O BIOCARDIA INC, 125 SHOREWAY ROAD SUITE B, SAN CARLOS CA 94070
David Mcclung officer: VP of Finance C/O BIOCARDIA, INC., 125 SHOREWAY ROAD, SUITE B, SAN CARLOS CA 94070
Allan R Tessler director C/O EPOCH HOLDING CORPORATION, 640 FIFTH AVENUE, NEW YORK, NY 10019
Richard T Allen officer: VP, Quality Assurance C/O BIOCARDIA, INC., 125 SHOREWAY ROAD, SUITE B, SAN CARLOS CA 94070
Thomas Quertermous director C/O BIOCARDIA INC, 125 SHOREWAY ROAD SUITE B, SAN CARLOS CA 94070

BioCardia (BioCardia) Headlines

From GuruFocus

BioCardia Announces $3.6 Million Private Placement of Common Stock

By Value_Insider Value_Insider 12-15-2022